Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention
- Conditions
- Anxiety
- Interventions
- Behavioral: PEACE Program
- Registration Number
- NCT05285306
- Lead Sponsor
- Duke University
- Brief Summary
The purpose of this study is to test the feasibility and acceptability of a brief coping skills training program addressing anxiety and pain related to surveillance pelvic examinations for female gynecologic cancer survivors.
- Detailed Description
The investigators have developed and manualized a coping skills training intervention for female gynecologic cancer patients that aims to reduce anxiety related to surveillance pelvic examinations (Pelvic Examination and Anxiety Coping Skills for Empowerment: PEACE). The investigators propose a proof-of concept pilot study to evaluate the acceptability and feasibility of the coping skills intervention. The study will be conducted by Duke University. Participants (N=16) will receive the 3-session telemedicine coping skills intervention. Participants will complete assessments at baseline, post-intervention (within 2 weeks before their next scheduled pelvic examination), and post pelvic examination (2-3 months after the baseline assessment). Study aims are: Aim 1) Assess intervention acceptability and feasibility through quantitative measurement and qualitative feedback from semi-structured interviews, and Aim 2) Graphically depict patterns of change in outcome variables and intervention targets.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 16
- female sex
- diagnosis of stage I-IV cervical or endometrial cancer
- 18 years of age or older
- able to speak/read English
- able to give informed consent
- completed cancer treatments within 2-24 months prior to enrollment, and recommended to undergo surveillance pelvic examination at three month intervals
- able to commit to three 45-60 minute visits within the study period
- able to participate in the intervention via the telemedicine modality (e.g., phone or video)
- unable to provide informed consent
- major untreated or uncontrolled mental illness
- hearing impairment that impedes telephone or video calls
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description PEACE Program PEACE Program 3 sessions of tailored coping skills related to pelvic examinations
- Primary Outcome Measures
Name Time Method Intervention feasibility as measured by attrition post pelvic examination (approximately 2-3 months after baseline) Retention logs will capture the number of participants who did not complete the study protocol (rate of attrition)
Intervention feasibility as measured by survey completion post pelvic examination (approximately 2-3 months after baseline) Retention logs will capture the number of participants who completed all assessments
Intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R) post pelvic examination (approximately 2-3 months after baseline) The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
Change in intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R) post-intervention (within 2 weeks of their next pelvic examination), post pelvic examination (approximately 2-3 months after baseline) Change in intervention acceptability from immediately after completion of the 3 sessions (post intervention assessment) to after trying to implement the coping skills during their next pelvic examination (post pelvic exam assessment), using the STTS-R. The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
Intervention feasibility as measured by percentage of recruited participants who enrolled post pelvic examination (approximately 2-3 months after baseline) Enrollment logs will capture the number of participants who were recruited and among them, the number that enrolled in the study.
Intervention feasibility as measured by home practice completion post-intervention (within 2 weeks of their next pelvic examination) Interventionist logs completed at the conclusion of each session will capture the level of home practice completion
Intervention feasibility as measured by participant engagement post-intervention (within 2 weeks of their next pelvic examination) Interventionist logs completed at the conclusion of each session will capture the level of participant engagement with a 1 item question rated from 1 (not at all engaged) to 4 (highly engaged).
Intervention feasibility as measured by interventionist fidelity post-intervention (within 2 weeks of their next pelvic examination) Fidelity rating forms will be used to measure the level of fidelity to session content for one third of the sessions for the protocol. Each component of the session will be rated from 0 (not covered at all) to 3 (thoroughly covered the topic)
- Secondary Outcome Measures
Name Time Method Change in anxiety related to examination as measured by the The State Anxiety Scale of the State-Trait Anxiety Inventory baseline, post-intervention (within 2 weeks of their next pelvic examination), post pelvic examination (approximately 2-3 months after baseline) The State Anxiety Scale of the STAI is comprised of 20 items on a 5-point Likert scale, which range from 1 (not at all) through 4 (very much).
Change in pain during examination as measured by numeric scales baseline, post pelvic examination (approximately 2-3 months after baseline) Numeric scales will be used to assess the average pain during examination, worst pain during examination, and lowest pain during examination, ranging from 0 (no pain) to 10 (pain as bad as you could imagine). The three pain intensity ratings will be averaged to create a total score for pain.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Duke University Medical Center
🇺🇸Durham, North Carolina, United States